Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10899736 Processes and intermediates for making a JAK inhibitor

Patent 10899736 was granted and assigned to Incyte on January, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

January 26, 2021

Patent Application Number

16260578

Date Filed

January 29, 2019

Patent Citations

US Patent 10398699 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

Patent Citations Received

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11324749 Combination therapy for treatment of hematological diseases

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)

0

Patent Primary Examiner

Patent abstract

This invention relates to processes and intermediates for making {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, useful in the treatment of diseases related to the activity of Janus kinases (JAK) including inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10899736 Processes and intermediates for making a JAK inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.